Apple looking likely to take a hit as Optis' UK SEPs appeal draws to a close

By Melissa Ritti ( March 3, 2025, 13:21 GMT | Comment) -- How far might the UK Court of Appeal go in cleaning up a lower court’s licensing terms for Apple to Optis Cellular Technology’s standard essential patent portfolio? That looks to be the primary question after four days of argument last week in London, with one more under way today. The “building blocks” for a Frand determination were all before High Court Judge Marcus Smith, but he chose not to rely on them, appeal judges were told. The odds of Apple emerging without owing Optis more than the $62 million ordered by Smith appear slim.The UK High Court's determination of a fair, reasonable and nondiscriminatory, or Frand, license for Apple to pay Optis Cellular Technology for its portfolio of standard essential patents appears to be on the chopping block....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.

Know what others in the room don’t, with features including:

Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Apple looking likely to take a hit as Optis' UK SEPs appeal draws to a close

Prepare for tomorrow’s regulatory change, today

Related Sections